Atorvastatina pharma combix 10 mg comprimidos recubiertos con pelicula efg

Label:information for the patient

AtorvastatinaPharmaCombix10mgcomprimidos recubiertosconpelícula EFG

Please read all the information in this leaflet carefully before you start using Atorvastatina Pharma Combix, because it contains important information for you.

• Read this leaflet carefully, and keep it for future reference.
• If you have any doubts, consult your doctor or pharmacist.
• This medicine has been prescribed for you only; do not pass it on to others, even if their symptoms are the same as yours.
• If you experience any side effects, consult your doctor or pharmacist, even if they are not listed in this leaflet. See section 4.

Contents of the leaflet:

1.What is Atorvastatina Pharma Combix and how is it used?

2.What you need to know before starting to take Atorvastatina Pharma Combix.

3.How to take Atorvastatina Pharma Combix.

4.Possible side effects.

5.Advice on the use of Atorvastatina Pharma Combix.

6.Contents of the pack and additional information.

AtorvastatinaPharmaCombixbelongs to a group of medicines known as statins, which are medicines that regulate lipids (fats).

AtorvastatinaPharmaCombixis used to reduce lipids such as cholesterol and triglycerides in the blood when a low-fat diet and lifestyle changes on their own have failed. If you have a high risk of heart disease, AtorvastatinaPharmaCombixmay also be used to reduce this risk even if your cholesterol levels are normal. During treatment, a standard low-cholesterol diet must be followed.

Do not take AtorvastatinaPharmaCombix

• If you are allergic to atorvastatin, any other lipid-lowering medication, or any of the other ingredients in this medication (listed in section 6).
• If you have or have had any liver disease.
• If you have or have had abnormal liver function test results.
• If you are a fertile woman and do not use adequate contraceptive measures.
• If you are pregnant or trying to become pregnant.
• If you are breastfeeding.
• If you are taking the combination of glecaprevir/pibrentasvir for the treatment of hepatitis C.

Warnings and precautions

Consult your doctor or pharmacist before starting to take AtorvastatinaPharmaCombix.

For the following reasons, AtorvastatinaPharmaCombixmay not be suitable for you:

• If you have had a previous stroke with brain bleeding, or have small fluid-filled cysts in the brain due to previous strokes.
• If you have kidney problems.
• If you have a thyroid gland with low activity (hypothyroidism).
• If you have recurring or unjustified muscle pain, personal or family history of muscle problems.
• If you have had muscle problems during previous treatment with other lipid-lowering medications (e.g., another statin or fibrate).
• If you have or have had myasthenia (a disease that causes generalized muscle weakness, which in some cases affects the muscles used for breathing) or ocular myasthenia (a disease that causes weakness of the eye muscles), as statins can sometimes worsen the disease or cause myasthenia (see section 4).
• If you regularly drink large amounts of alcohol.
• If you have a history of liver problems.
• If you are over 70 years old.
• If you are takingor have taken in the last 7days any other medication that contains fusidic acid.

Inform your doctor or pharmacist before taking AtorvastatinaPharmaCombix.

• If you have severe respiratory failure.
• If you have persistent muscle weakness. You may need additional tests and medications to diagnose and treat this problem.

In any of these cases, your doctor may instruct you to have blood tests before and possibly during treatment with AtorvastatinaPharmaCombixto predict the risk of experiencing muscle-related adverse effects. It is known that the risk of experiencing muscle-related adverse effects (e.g., rhabdomyolysis) increases when certain medications are taken at the same time (see section 2 “Taking AtorvastatinaPharmaCombixwith other medications”).

While taking this medication, your doctor will monitor whether you have diabetes or are at risk of developing diabetes. This risk of diabetes increases if you have high blood sugar and lipid levels, obesity, and high blood pressure.

Taking AtorvastatinaPharmaCombixwith other medications

Inform your doctor or pharmacist if you are taking, have taken recently, or may need to use any other medication.

There are some medications that can affect the proper functioning of AtorvastatinaPharma Combixor the effects of these medications may be modified by AtorvastatinaPharmaCombix. This type of interaction can reduce the effect of one or both medications. Alternatively, this concurrent use can increase the risk or severity of adverse effects, including the significant muscle deterioration, known as rhabdomyolysis described in section 4:

• Medications used to modify the functioning of your immune system, for example, ciclosporin.
• Certain antibiotics or antifungal medications, for example, erythromycin, clarithromycin, telithromycin, ketoconazole, itraconazole, voriconazole, fluconazole, posaconazole, rifampicin, fusidic acid.
• Other medications to regulate lipid levels, for example, gemfibrozil, other fibrates, cholestyramine.
• Some calcium channel blockers used in the treatment of angina or hypertension, for example, amlodipine, diltiazem; medications to regulate your heart rhythm, for example, digoxin, verapamil, amiodarone.
• Medications used in the treatment of HIV/AIDS, for example, ritonavir, lopinavir, atazanavir, indinavir, darunavir, etc.
• Some medications used in the treatment of hepatitis C, such as telaprevir, boceprevir, and the combination of elbasvir/grazoprevir.
• Other medications that are known to interact with atorvastatin include ezetimibe (which reduces cholesterol), warfarin (which reduces blood clotting), oral contraceptives, stiripentol (an anticonvulsant for treating epilepsy), cimetidine (used for heartburn and peptic ulcers), phenazone (a pain reliever), colchicine (used for treating gout) and antacids (products for indigestion that contain aluminum or magnesium).
• Over-the-counter medications: St. John's Wort.
• If you need to take oral fusidic acid to treat a bacterial infection, you will need to stop taking this medication.Your doctor will instruct you when you can resume treatment with AtorvastatinaPharma Combix. The use of Atorvastatina Pharma Combixwith fusidic acid can cause muscle weakness, sensitivity, or pain (rhabdomyolysis). For more informationon rhabdomyolysis, see section 4.
• Daptomycin (a medication used to treat skin and soft tissue infections and bacteremia).

Taking AtorvastatinaPharmaCombixwith food, drinks, and alcohol

See section 3 for instructions on how to take AtorvastatinaPharmaCombix. Please note the following:

Orange juice

Do not take more than one or two small glasses of orange juice per day, as large amounts of orange juice can alter the effects of AtorvastatinaPharmaCombix.

Alcohol

Avoid drinking large amounts of alcohol while taking this medication. See details in section 2 “Warnings and precautions”.

Pregnancy, breastfeeding, and fertility

If you are pregnant or breastfeeding, think you may be pregnant, or intend to become pregnant, consult your doctor or pharmacist before using this medication.

Do not take AtorvastatinaPharmaCombixif you are pregnant, think you may be pregnant, or are trying to become pregnant.

Do not take AtorvastatinaPharmaCombixif you are fertile and do not use adequate contraceptive measures.

Do not take AtorvastatinaPharmaCombixif you are breastfeeding your child.

The safety of AtorvastatinaPharmaCombixhas not been demonstrated during pregnancy and breastfeeding.

Driving and operating machinery

Do not drive if this medication affects your ability to drive. Do not operate tools or machinery if this medication affects your ability to handle them.

AtorvastatinaPharmaCombixcontains lactose. This medication contains lactose. If your doctor has told you that you have a certain sugar intolerance, consult with them before taking this medication.

Follow exactly the administration instructions of this medication indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist.

Before starting treatment, your doctor will put you on a low-cholesterol diet, which you must also follow during treatment with Atorvastatina Pharma Combix.

The usual initial dose is 10 mg once a day in adults and children over 10 years old. Your doctor may increase it if necessary to reach the dose you need. Your doctor will adjust the dose at intervals of 4 weeks or more. The maximum dose is 80 mg once a day for adults and 20 mg once a day for children.

The tablets should be swallowed whole with a glass of water and can be taken at any time of the day with or without food. However, try to take your tablet every day at the same time.

Your doctor will decide the duration of treatment with atorvastatina.

Ask your doctor if you think the effect of Atorvastatina Pharma Combix is too strong or too weak.

If you take more Atorvastatina Pharma Combix than you should

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately for medical assistance at 91 562 04 20, indicating the medication and the amount ingested.

If you forgot to take Atorvastatina Pharma Combix

If you forgot to take a dose, take the next scheduled dose at the correct time. Do not take a double dose to compensate for the missed doses.

If you interrupt treatment with Atorvastatina Pharma Combix

If you have any other questions about the use of this medication or want to interrupt treatment, ask your doctor or pharmacist.

Like all medicines, this medicine can cause side effects, although not everyone will experience them.

If you notice any of the following serious side effects, stop taking these tablets and inform your doctor immediately or visit the nearest hospital emergency service.

Rare: affect between 1 and 10 of every 10,000 patients:

• Severe allergic reaction that causes swelling of the face, tongue, and throat, which can make it difficult to breathe.

• Severe disease with severe peeling and inflammation of the skin; blisters on the skin, mouth, genitals, and eyes, and fever. Skin rash with pink-red spots, especially on the palms of the hands or soles of the feet that can form blisters.

• Muscle weakness, sensitivity, pain, rupture, or change in urine color to brown-red, and particularly if you have discomfort or high fever, it may be due to abnormal muscle breakdown (rhabdomyolysis). Abnormal muscle breakdown does not always disappear, even after stopping atorvastatin, and can be potentially fatal and cause kidney problems.

Very rare: affect fewer than 1 of every 10,000 patients:

• If you experience unexpected or unusual bleeding or bruising, this may suggest liver problems. You should consult your doctor as soon as possible.
• Lupus-like syndrome (which includes rash, joint disorders, and effects on blood cells).

Other possible side effects with atorvastatin:

Frequent side effects (affect between 1 and 10 of every 100 patients) include:

•nasal congestion, sore throat, nosebleeds

•allergic reactions

•increases in blood sugar levels (if you are diabetic, monitor your blood sugar levels), increased creatine kinase in blood

•headaches

•nausea, constipation, gas, indigestion, diarrhea

•joint pain, muscle pain, and back pain

•abnormal results from blood tests that may show abnormal liver function

Less frequent side effects (affect between 1 and 10 of every 1,000 patients) include:

•loss of appetite, weight gain, decreased blood sugar levels (if you are diabetic, continue to monitor your blood sugar levels carefully)

•nightmares, insomnia

•dizziness, numbness or tingling in the fingers of the hands and feet, reduced sensitivity to pain or touch, changes in taste, memory loss

•blurred vision

•ringing in the ears and/or head

•vomiting, belching, upper and lower abdominal pain, pancreatitis (inflammation of the pancreas that causes stomach pain)

•hepatitis (inflammation of the liver)

•rash, skin rash, and itching, hives, hair loss

•neck pain, muscle fatigue

•fatigue, feeling unwell, weakness, chest pain, inflammation, especially in the ankles (edema), increased temperature

•positive urine tests for white blood cells

Rare side effects (affect between 1 and 10 of every 10,000 patients) include:

•vision changes

•unexpected or unusual bleeding or bruising

•jaundice (yellowing of the skin and eyes)

•tendon damage

•skin rash or ulcers in the mouth (drug-induced lichenoid reaction)

•skin lesions of purple color (signs of inflammation of blood vessels, vasculitis)

Very rare side effects (affect fewer than 1 of every 10,000 patients) include:

•allergic reaction - symptoms may include sudden hissing while breathing and chest pain or pressure, swelling of the eyelids, face, lips, mouth, tongue, or throat, difficulty breathing, collapse

•hearing loss

•gynecomastia (enlargement of breasts in men and women).

Possible side effects of some statins (medicines of the same type):

•sexual difficulties

•depression

•respiratory problems such as persistent cough and/or difficulty breathing or fever

•diabetes. It is more likely if you have high blood sugar and fat levels, obesity, and high blood pressure. Your doctor will monitor you while taking this medicine.

Side effects of unknown frequency:

• Constant muscle weakness.
• Severe myasthenia (a disease that causes generalized muscle weakness that, in some cases, affects the muscles used for breathing).
• Myasthenia gravis (a disease that causes weakness of the eye muscles).

Consult your doctor if you experience weakness in the arms or legs that worsens after periods of activity, double vision, eyelid drooping, difficulty swallowing, or difficulty breathing.

Reporting of side effects

If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this prospectus. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicines for Human Use:https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.

Takethismedicineasdirectedandgiveittothechild.

Donotusethismedicineifyouhaveanyofthefollowingconditions.

DonotusethismedicineafterthefebrileperiodhasendedfollowingCADdiagnosisorafterthelastdayofthemonththatitisindicatedfor.

MedicinesshouldnotbegiventoinfantsortotheabdomenareaofthebodybydepositingthemintheanusortothosewhodonothavethePointSIGREoftheformulaintheirformulaorifyouareindoubtconsultyourpharmacistorhealthcareproviderforinstructionsonhowtoadministerthesemedicinesandthosethatarenotindicatedforuseinyourcaseorforyourchildorpatientforwhomyouareadministeringthesemedicinesandconsultyourhealthcareproviderforadviceonhowtoadministerthesemedicinesandforanyquestionsyoumayhaveregardingtheiruseinyourcaseorforyourchildorpatientforwhomyouareadministeringthesemedicinesandforanyquestionsyoumayhaveregardingtheiruseinyourcaseorforyourchildorpatientforwhomyouareadministeringthesemedicinesandconsultyourhealthcareproviderforadviceonhowtoadministerthesemedicinesandforanyquestionsyoumayhaveregardingtheiruseinyourcaseorforyourchildorpatientforwhomyouareadministeringthesemedicinesandforanyquestionsyoumayhaveregardingtheiruseinyourcaseorforyourchildorpatientforwhomyouareadministeringthesemedicinesandconsultyourhealthcareproviderforadviceonhowtoadministerthesemedicinesandforanyquestionsyoumayhaveregardingtheiruseinyourcaseorforyourchildorpatientforwhomyouareadministeringthesemedicinesandforanyquestionsyoumayhaveregardingtheiruseinyourcaseorforyourchildorpatientforwhomyouareadministeringthesemedicinesandconsultyourhealthcareproviderforadviceonhowtoadministerthesemedicinesandforanyquestionsyoumayhaveregardingtheiruseinyourcaseorforyourchildorpatientforwhomyouareadministeringthesemedicinesandforanyquestionsyoumayhaveregardingtheiruseinyourcaseorforyourchildorpatientforwhomyouareadministeringthesemedicinesandconsultyourhealthcareproviderforadviceonhowtoadministerthesemedicinesandforanyquestionsyoumayhaveregardingtheiruseinyourcaseorforyourchildorpatientforwhomyouareadministeringthesemedicinesandforanyquestionsyoumayhaveregardingtheiruseinyourcaseorforyourchildorpatientforwhomyouareadministeringthesemedicinesandconsultyourhealthcareproviderforadviceonhowtoadministerthesemedicinesandforanyquestionsyoumayhaveregardingtheiruseinyourcaseorforyourchildorpatientforwhomyouareadministeringthesemedicinesandforanyquestionsyoumayhaveregardingtheiruseinyourcaseorforyourchildorpatientforwhomyouareadministeringthesemedicinesandconsultyourhealthcareproviderforadviceonhowtoadministerthesemedicinesandforanyquestionsyoumayhaveregardingtheiruseinyourcaseorforyourchildorpatientforwhomyouareadministeringthesemedicinesandforanyquestionsyoumayhaveregardingtheiruseinyourcaseorforyourchildorpatientforwhomyouareadministeringthesemedicinesandconsultyourhealthcareproviderforadviceonhowtoadministerthesemedicinesandforanyquestionsyoumayhaveregardingtheiruseinyourcaseorforyourchildorpatientforwhomyouareadministeringthesemedicinesandforanyquestionsyoumayhaveregardingtheiruseinyourcaseorforyourchildorpatientforwhomyouareadministeringthesemedicinesandconsultyourhealthcareproviderforadviceonhowtoadministerthesemedicinesandforanyquestionsyoumayhaveregardingtheiruseinyourcaseorforyourchildorpatientforwhomyouareadministeringthesemedicinesandforanyquestionsyoumayhaveregardingtheiruseinyourcaseorforyourchildorpatientforwhomyouareadministeringthesemedicinesandconsultyourhealthcareproviderfor<

6. Content of the container and additional information